Dual function of programmed cell death 10 (PDCD10) in drug resistance

Date

2018-05-01

Author

Urfali-Mamatoglu, Cagri
Kazan, Hasan Huseyin
Gündüz, Ufuk

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

223
views

0
downloads

Drug resistance, a major challenge in cancer chemotherapy, is a result of several mechanistic alterations including resistance to apoptosis. Apoptosis is a well-controlled cell death mechanism which is regulated by several signaling pathways. Alterations in structure, function, and expression pattern of the proteins involved in the regulation of apoptosis have been linked to drug resistance. Programmed Cell Death 10 (PDCD10) protein is recently associated with the regulation of cell survival and apoptosis. However, the role of PDCD10 in drug resistance has not been clearly established. Here, we aimed to figure out the role of PDCD10 in resistance to anticancer agents in different cell lines. We found that PDCD10 expression was cell-and anti-cancer agent-specific; down-regulated in doxorubicin-and docetaxel-resistant MCF7 cells while up-regulated in doxorubicin-resistant HeLa cells. Down-regulation of PDCD10 expression by siRNA in parental MCF7 cells increased the resistance while it increased sensitivity in doxorubicin-resistant HeLa cells. Similarly, over-expression of PDCD10 in parental HeLa cells increased the resistance to doxorubicin while it re-sensitized doxorubicin-resistant MCF7 cells. Moreover, the alterations in PDCD10 expression led to changes in caspase 3/7 activity and the levels of apoptosis-related genes. Our results point out a possible dual role of PDCD10 in drug resistance for the first time in the literature and emphasize PDCD10 as a novel target for reversal of drug resistance in cancer.

Subject Keywords

Chemoresistance, Apoptosis, PDCD10, Programmed cell death

URI

https://hdl.handle.net/11511/29873

Journal

BIOMEDICINE & PHARMACOTHERAPY

DOI

https://doi.org/10.1016/j.biopha.2018.02.020

Collections

Graduate School of Natural and Applied Sciences, Article

Suggestions

OpenMETU
Core

Downregulation of Programmed Cell Death 10 (PDCD 10) Expression Confers Doxorubicin Resistance in Breast Cancer Cells Mamatoğlu, Çağrı Urfalı; Kazan, Hasan Hüseyin; Gündüz, Ufuk (null; 2017-10-08) Dysregulated apoptosis is one of the major drug resistance mechanisms. Programmed cell death 10 (PDCD10) is a novel apoptosis regulator, involving in modulation of apoptosis and cell survival. Despite its importance in apoptotic regulation, the role of PDCD10 in drug resistance has not been understood yet. We screened parental and doxorubicin-resistant MCF7, HeLa and K562 cells for PDCD10 expression. Our results showed that PDCD10 expression is cell-specific; significantly downregulated in MCF7 and upregula...
Investigation of the role of programmed cell death 10 (PDCD10) protein in multidrug resistance Urfalı Mamatoğlu, Çağrı; Gündüz, Ufuk; Department of Biology (2018) Drug resistance, a major obstacle in chemotherapy, is the sum of several cellular alterations including resistance to induction of apoptosis. Apoptosis is a well-regulated cell death mechanism which is controlled by several signaling pathways and a vast number of proteins. Alterations in the proteins involved in the apoptotic regulation have been associated with drug resistance in cancer. Programmed Cell Death 10 (PDCD10) protein is a novel apoptotic regulator that is recently linked to the modulation of ce...
Investigation of docetaxel and doxorubicin resistance in mcf-7 breast carcinoma cell line Darcansoy İşeri, Özlem; Gündüz, Ufuk; Department of Biotechnology (2009) Multidrug resistance phenotype of tumor cells describes resistance to wide range of structurally unrelated anticancer agents and is a serious limitation to effective chemotherapy. It is a multifactor yet not fully elucidated phenomenon by the involvement of diverse cellular pathways. Aim of this study was to investigate the resistance mechanisms developed against docetaxel and doxorubicin that are widely used in the treatment of breast cancer in model cell line MCF-7. Resistant sublines were developed by ap...
Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines Kars, Meltem Demirel; Iseri, Ozlem Darcansoy; Gündüz, Ufuk; Molnar, Jozsef (2008-01-01) Background: Ineffectiveness of anticancer drugs is frequently observed in cancer chemotherapy. The resistance of tumor cells to various cytotoxic drugs is defined as multidrug resistance (MDR). The purpose of this study is to investigate the potential reversal effect of some synthetic and natural chemicals on drug-resistant MCF-7 cell lines. The effects of potential MDR modulators combined with some anticancer drugs were also studied. Methods: Flow cytometry, MTT cytotoxicity assays and checkerboard combina...
Reversal of breast cancer resistance protein mediated multidrug resistance in MCF7 breast adenocarcinoma cell line Urfalı, Çağrı; Gündüz, Ufuk; Department of Biology (2011) Resistance to various chemotherapeutic agents is a major problem in success of cancer chemotherapy. One of the primary reasons of development of multidrug resistance (MDR) is the overexpression of ATP binding cassette (ABC) transporter proteins. Breast cancer resistance protein (BCRP) belongs to ABC transporter family and encoded by ABCG2 gene. BCRP is mainly expressed in MDR1 (P-glycoprotein) lacking breast cancer cells. Overexpression of BCRP leads to efflux of chemotherapeutic agents at higher rates, the...

Citation Formats

C. Urfali-Mamatoglu, H. H. Kazan, and U. Gündüz, “Dual function of programmed cell death 10 (PDCD10) in drug resistance,” BIOMEDICINE & PHARMACOTHERAPY, pp. 129–136, 2018, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/29873.